Intas Pharma appoints Dr Ajay Kumar Handa as new Executive Vice President - RnD

Written by Ruchika Sharma Published On 2025-09-11T17:23:47+05:30 | Updated On 11 Sept 2025 5:23 PM IST

Intas Pharma appoints Dr Ajay Kumar Handa as new Executive Vice President - RnD

Ahmedabad: Intas Pharma has announced the appointment of Dr Ajay Kumar Handa as its new Executive Vice President - R&D.

The announcement was made via the company’s official LinkedIn page, stating, "We are delighted to welcome Dr Ajay Kumar Handa as Executive Vice President – R&D at Intas Pharmaceuticals."

Bringing over three decades of extensive experience in pharmaceutical research and development, Dr. Ajay has spearheaded the advancement of generics and Novel Drug Delivery Systems (NDDS) across diverse dosage forms, including solid orals, liquids, injectables, new chemical entities (NCEs), and dry powder inhalation.

Prior to joining Intas, Dr. Handa held several senior leadership roles at major pharmaceutical companies. He served as Executive Vice President and Global Head – OSD at Dr. Reddy's Laboratories, and previously held key R&D positions including President – R&D at Cadila Pharmaceuticals, Senior Vice President at Wockhardt, and Vice President at Zydus Cadila Healthcare. His career also includes impactful tenures at Alembic Pharmaceuticals, Ranbaxy Laboratories, and Panacea Biotec.

Read also: Intas Pharma ropes in Nitin Goyal as Associate Vice President - Operations

Intas is a vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. Intas has set up a network of subsidiaries, under the umbrella name of Accord Healthcare to operate in global markets. Over the years, Intas has grown both organically and via acquisition, expanding its product portfolio and operations year on year. It is currently present in more than 85 countries worldwide. Intas is currently investing in a higher barrier to entry developments such as Biosimilar and New Chemical Entities.

intas pharmaintas pharma newsappointmentDr Ajay Kumar Handa

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751